banner
Products
Trusted supplier with a track record of excellence
New Antidiabetes Pharmaceutical PF

New Antidiabetes Pharmaceutical PF

New Antidiabetes Pharmaceutical PF-04971729 CAS 1210344-57-2 Ertugliflozin PF-04971729 Function of Ertugliflozin Temozol;
Basic Info.
Model NO. HRK-PF-04971729
Assay 90% Min
Grade Standard Feed Grade, Food Grade, Medicine Grade
Certificate GMP ISO USP Bp
Sample Ertugliflozin Avaliable
Storage Cool Dry Place
Shelf Life 2 Years Proper Storage
Type of Product Auxiliaries and Other Medicinal Chemicals
Application PF-04971729 Raw Materials
CAS 1210344-57-2
Mf C22h25clo7
Active Ingredient PF-04971729
MW 436.129
Appearance White or White Crystalline Powder
Test HPLC
Product Name PF-04971729 Powder
Transport Package 1kg Per Foil Bag, 10 Bags Per Carton. 25 Kg Per Dr
Specification 99% min PF-04971729
Trademark Henrikang
Origin Shaanxi China
Production Capacity 500000kg/Year
Product Description
New Antidiabetes Pharmaceutical PF-04971729 CAS 1210344-57-2 Ertugliflozin PF-04971729
Product NameNew Antidiabetes Pharmaceutical PF-04971729 CAS 1210344-57-2 Ertugliflozin PF-04971729
CAS1210344-57-2
AppearanceWhite or white crystalline powder
Molecular formulaC22H25ClO7
Molecular Weight436.129
Assay98%
Shelf Life24 months when properly stored
StorageKeep in a cool, dry, dark location

What is Ertugliflozin?

Ertugliflozin is an antidiabetic drug. Ertugliflozin is used to improve glycemic control in people with type 2 diabetes,Egagliflozin is a new class of SGLT2 inhibitors co-developed by Pfizer and Merck. In December 2017, the US FDA approved its marketing under the trade name Steglatro. It has been clinically used in the treatment of adult patients with type 2 diabetes, but it has not been marketed in China. Ertugliflozin series impurities are used for research and examination of related substances in ertugliflozin drug research.

Function of Ertugliflozin

Temozolomide is used in the treatment of adults with refractory pleomorphic glioblastoma and anaplasticastrocytoma of chemotherapy drugs.Egagliflozin is a new class of SGLT2 inhibitors co-developed by Pfizerand Merck. In December 2017, the US FDA approved its marketing under the trade name Steglatro. It hasbeen clinically used in the treatment of adult patients with type 2 diabetes, but it has not been marketed inChina. Ertugliflozin series impurities are used for research and examination of related substances in ertugliflozindrug research.
Company InformationOur CertificateOur ServiceOur ResearchPackaging & Logistics

Package:

1kg per Foil Bag, 10 Bags per carton. 25 kg per Drum. Or Customized Package.

2. Shipping Advise:

1. By Express------Suitable for under 50kg, Fast:3-4 days. High cost; Door to door service. Easy to pick up the goods.2. By Air ------Suitable for more than 50 kg, Fast:4-5 days, High cost, airport to airport. professional broker needed.3. By sea------Suitable for more than 500kg. Slow: 15-45 days, Low cost. Port to Port, professional broker needed.
why choose us ?New Antidiabetes Pharmaceutical PF-04971729 CAS 1210344-57-2 Ertugliflozin PF-04971729Ertugliflozin;PF-04971729;Ertugliflozin Powder
Send inquiry